mutations and complex kar yotype. It follows a linear evolution in the CLL clone from the recurrent acquisition of CDKN2A??? "???????????????????????????????????????????????"102 However, several teams are advocating to the incorporation of novel markers, like a complicated karyotype55 or epigenetic subsets, 27,28 into scientific practice. These nov